Focal segmental glomerular sclerosis (FSGS) is 1 of the primary causes of nephrotic
syndrome in both pediatric and adult patients, which can lead to end-stage kidney disease …

Membranous nephropathy (MN) is a leading cause of kidney failure worldwide and
frequently recurs after transplant. Available data originated from small retrospective cohort …

Background Focal segmental glomerulosclerosis (FSGS) is divided into genetic, primary (p),
uncertain cause, and secondary (s) forms. The subclasses differ in management and …

Rationale & Objective Sparsentan is a novel, non-immunosuppressive, single-molecule,
dual endothelin angiotensin receptor antagonist (DEARA) examined in the ongoing phase 2 …

Introduction Posttransplant disease recurrence is a feared and severe complication in
children with steroid resistant nephrotic syndrome (SRNS), but little is known about its …

The advances in acute phase care have firmly established the practice of organ
transplantation in the last several decades. Then, the next issues that loom large in the field …

Focal segmental glomerulosclerosis (FSGS) is a common cause of nephrotic syndrome and
whilst advances have been made in the pathophysiology, diagnostics and management of …

Upon physical examination, the patient was afebrile with a blood pressure of 140/80 mmHg,
and there was noticeable edema. He had gained 10 kg (from 83 kg to 93 kg) within 1 week …

Rituximab (RTX) therapy for primary focal segmental glomerulosclerosis recurrence after
kidney transplantation (KT) has been extensively debated. We aimed to assess the benefit of …

The spectra of underlying genetic variants for various clinical entities including focal
segmental glomerulosclerosis (FSGS) vary among different populations. Here we described …